Picture of AtaiBeckley logo

ATAI — AtaiBeckley News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Atai Life Sciences NV - Study Shows Bpl-003 Demonstrates Rapid, Robust And Durable Antidepressant Effects

July 1 (Reuters) - ATAI Life Sciences NV 9VC.DE:

ATAI LIFE SCIENCES AND BECKLEY PSYTECH ANNOUNCE POSITIVE TOPLINE RESULTS FROM THE PHASE 2B STUDY OF BPL-003 IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

ATAI LIFE SCIENCES NV - STUDY SHOWS BPL-003 DEMONSTRATES RAPID, ROBUST AND DURABLE ANTIDEPRESSANT EFFECTS

ATAI LIFE SCIENCES NV: STUDY MET ITS PRIMARY AND ALL KEY SECONDARY ENDPOINTS

ATAI LIFE SCIENCES NV - BPL-003 WELL-TOLERATED WITH NO SERIOUS ADVERSE EVENTS OR SUICIDE-RELATED SAFETY SIGNALS

Source text: ID:nGNX4pCjHv

Further company coverage: 9VC.DE

 (((( Reuters.briefs@thomsonreuters.com ;));))

Recent news on AtaiBeckley

See all news